Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's ...

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

Older women who underwent hormone replacement therapy during and after menopause had high markers associated with Alzheimer's ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...

Diagnosing Alzheimer's disease before people have any symptoms is possible, but brings up concerns when so few treatments are ...

Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

A new study from Mass General Brigham researchers has found faster accumulation of tau-a key indicator of Alzheimer's disease-in the brains of women over the age of 70 who took menopausal hormone ...

Researchers in Sarnia are participating in a clinical trial evaluating a drug that could help delay the onset of Alzheimer’s ...